These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23754925)

  • 41. Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients.
    Newman CB; Palmer G; Silbershatz H; Szarek M
    Am J Cardiol; 2003 Sep; 92(6):670-6. PubMed ID: 12972104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of the Risk of Rhabdomyolysis and Myopathy During Concomitant Treatment with Ticagrelor and Statins.
    Danielak D; Karaźniewicz-Łada M; Główka F
    Drugs; 2018 Jul; 78(11):1105-1112. PubMed ID: 30003466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.
    Molden E; Skovlund E; Braathen P
    Drug Saf; 2008; 31(7):587-96. PubMed ID: 18558792
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
    Watkins JL; Atkinson BJ; Pagliaro LC
    Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature.
    Patoulias D; Michailidis T; Papatolios T; Papadopoulos R; Keryttopoulos P
    Case Rep Nephrol; 2017; 2017():2187264. PubMed ID: 29119029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin-associated polymyositis following omeprazole treatment.
    Kanth R; Shah MS; Flores RM
    Clin Med Res; 2013 Jun; 11(2):91-5. PubMed ID: 23580790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological interactions of statins.
    Paoletti R; Corsini A; Bellosta S
    Atheroscler Suppl; 2002 May; 3(1):35-40. PubMed ID: 12044584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent use of statins and amiodarone.
    Borders-Hemphill V
    Consult Pharm; 2009 May; 24(5):372-9. PubMed ID: 19555146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myopathy associated with atorvastatin-ezetimibe combination therapy.
    Weffald LA; Flach LA
    Pharmacotherapy; 2007 Feb; 27(2):309-11. PubMed ID: 17253923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of HMG-CoA reductase inhibitors: focus on atorvastatin.
    Bernini F; Poli A; Paoletti R
    Cardiovasc Drugs Ther; 2001; 15(3):211-8. PubMed ID: 11713888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simvastatin-fluconazole causing rhabdomyolysis.
    Shaukat A; Benekli M; Vladutiu GD; Slack JL; Wetzler M; Baer MR
    Ann Pharmacother; 2003; 37(7-8):1032-5. PubMed ID: 12841814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
    Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
    Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhabdomyolysis after taking atorvastatin with gemfibrozil.
    Duell PB; Connor WE; Illingworth DR
    Am J Cardiol; 1998 Feb; 81(3):368-9. PubMed ID: 9468088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of ADRs associated with lipid-lowering agents recorded in the Department of Internal Medicine, University Hospital, Jena.
    Hippius M; Farker K; Helble S; Hoffmann A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):97-101. PubMed ID: 11911604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
    Mackay JW; Fenech ME; Myint KS
    Br J Hosp Med (Lond); 2012 Feb; 73(2):106-7. PubMed ID: 22504754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death.
    Mohamed MFH; Salameh OK; Saeed AAM
    Am J Case Rep; 2019 May; 20():709-712. PubMed ID: 31101801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
    Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
    Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.